1 study found for:    23190342 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of IncobotulinumtoxinA (Xeomin) in the Treatment of Glabellar Frown Lines
Condition: Glabellar Lines
Intervention: Drug: IncobotulinumtoxinA (Xeomin) (20 units)

Indicates status has not been verified in more than two years